TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA LDL TEST MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 NORTH AMERICA LDL TEST MARKET: GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 DBMR MARKET POSITION GRID
2.7 DBMR MARKET CHALLENGE MATRIX
2.8 DBMR VENDOR SHARE ANALYSIS
2.9 MULTIVARIATE MODELING
2.10 PRODUCTS LIFELINE CURVE
2.11 KEY PRIMARY INSIGHTS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISING AWARENESS AMONG PATIENT
3.1.2 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES AND OBESITY
3.1.3 INCREASING NUMBER OF GERIATRIC PEOPLE
3.1.4 GOVERNMENT INITIATIVES TO IMPROVE QUALITY OF TESTING
3.2 RESTRAINTS
3.2.1 RISKS ASSOCIATED WITH TESTS LIKE BLEEDING AND INFECTION
3.2.2 EMERGENCE OF NON-INVASIVE CHOLESTEROL TESTING METHODS
3.3 OPPORTUNITIES
3.3.1 HIGH GROWTH POSSIBILITY IN LDL TEST IN DEVELOPING COUNTRIES
3.3.2 PATIENT-INITIATED TESTING
3.4 CHALLENGES
3.4.1 PATIENT DATA SECURITY
3.4.2 EVOLVING REGULATORY POLICIES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA LDL TEST MARKET, BY COMPONENTS
6.1 OVERVIEW
6.2 KITS & REAGENTS
6.3 DEVICES
6.3.1 SPECTROPHOTOMETER
6.3.2 SYRINGES AND NEEDLES
6.3.3 OTHERS
6.4 SERVICES
7 NORTH AMERICA LDL TESTING MARKET, BY DISEASE
7.1 OVERVIEW
7.2 DIABETES
7.3 STROKE
7.4 ATHEROSCLEROSIS
7.5 OBESITY
7.6 DYSLIPIDEMIA
7.7 CAROTID ARTERY DISEASE
7.8 PERIPHERAL ARTERIAL DISEASE
7.9 ANGINA
7.10 OTHERS
8 NORTH AMERICA LDL TEST MARKET, BY DISTRIBUTION CHANNEL
8.1 OVERVIEW
8.2 DIRECT TENDERS
8.3 RETAIL
9 NORTH AMERICA LDL TEST MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS
9.3 CLINICS
9.4 AMBULATORY CARE
9.5 RESEARCH LABORATORY
?
10 NORTH AMERICA LDL TEST MARKET, BY GEOGRAPHY
10.1 NORTH AMERICA
10.1.1 U.S.
10.1.2 CANADA
10.1.3 MEXICO
11 NORTH AMERICA LDL TEST MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
12 SWOT ANALYSIS
12.1 STRENGTH
12.2 WEAKNESS
12.3 OPPORTUNITY
12.4 THREAT
12.5 DATA BRIDGE MARKET RESEARCH ANALYSIS
13 COMPANY PROFILE
13.1 F. HOFFMANN-LA ROCHE LTD
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 GEOGRAPHICAL PRESENCE
13.1.5 PRODUCT PORTFOLIO
13.1.6 RECENT DEVELOPMENTS
13.2 MERCK KGAA
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 GEOGRAPHICAL PRESENCE
13.2.5 PRODUCT PORTFOLIO
13.2.6 RECENT DEVELOPMENT
13.3 ABBOTT
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 GEOGRAPHICAL PRESENCE
13.3.5 PRODUCT PORTFOLIO
13.3.6 RECENT DEVELOPMENTS
?
13.4 SEKISUI DIAGNOSTICS
13.4.1 COMPANY SNAPSHOT
13.4.2 COMPANY SHARE ANALYSIS
13.4.3 GEOGRAPHICAL PRESENCE
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENT
13.5 ATLAS MEDICAL U.K
13.5.1 COMPANY SNAPSHOT
13.5.2 GEOGRAPHICAL PRESENCE
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENTS
13.6 CELL BIOLABS, INC
13.6.1 COMPANY SNAPSHOT
13.6.2 GEOGRAPHICAL PRESENCE
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENTS
13.7 DIASYS DIAGNOSTIC SYSTEMS GMBH
13.7.1 COMPANY SNAPSHOT
13.7.2 GEOGRAPHICAL PRESENCE
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENT
13.8 DIAZYME LABORATORIES, INC
13.8.1 COMPANY SNAPSHOT
13.8.2 GEOGRAPHICAL PRESENCE
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENTS
13.9 EUROFINS SCIENTIFIC
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 GEOGRAPHICAL PRESENCE
13.9.4 PRODUCT PORTFOLIO
13.9.5 RECENT DEVELOPMENT
13.10 EUROLYSER DIAGNOSTICA GMBH
13.10.1 COMPANY SNAPSHOT
13.10.2 GEOGRAPHICAL PRESENCE
13.10.3 PRODUCT PORTFOLIO
13.10.1 RECENT DEVELOPMENTS
?
13.11 EXPRESS BIOTECH INTERNATIONAL
13.11.1 COMPANY SNAPSHOT
13.11.2 GEOGRAPHICAL PRESENCE
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT DEVELOPMENTS
13.12 HOME ACCESS HEALTH
13.12.1 COMPANY SNAPSHOT
13.12.2 PRODUCT PORTFOLIO
13.12.3 RECENT DEVELOPMENTS
13.13 LABORATORY CORPORATION OF AMERICA
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 GEOGRAPHICAL PRESENCE
13.13.4 PRODUCT PORTFOLIO
13.13.5 RECENT DEVELOPMENTS
13.14 QUEST DIAGNOSTICS
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 GEOGRAPHICAL PRESENCE
13.14.4 PRODUCT PORTFOLIO
13.14.5 RECENT DEVELOPMENT
13.15 RANDOX LABORATORIES LTD
13.15.1 COMPANY SNAPSHOT
13.15.2 GEOGRAPHICAL PRESENCE
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENT
13.16 RECKONDIAGNOSTICS
13.16.1 COMPANY SNAPSHOT
13.16.2 PRODUCT PORTFOLIO
13.16.3 RECENT DEVELOPMENTS
13.17 THERMO FISHER SCIENTIFIC INC
13.17.1 COMPANY SNAPSHOT
13.17.2 REVENUE ANALYSIS
13.17.3 GEOGRAPHICAL PRESENCE
13.17.4 PRODUCT PORTFOLIO
13.17.5 RECENT DEVELOPMENTS
?
14 CONCLUSION
15 QUESTIONNAIRE
16 RELATED REPORTS